Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Study of the Efficacy Safety and Acceptability-275013319
Magee-Womens Health Corp.
Search grants from Magee-Womens Health Corp.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
High Throughput Screening for Non-antibiotic inhibitors of Clostridium difficile Pathophysiology
Molecular Biophysics Training Program at Stanford
Automated Segmentation of Components in Macromolecular
Fluorescence Study of Drugs
Surgical Pathology
Recently added grants:
'Two year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia'
Basic and Clinical Studies in Reinforcing Positive Behaviors in Intellectual and Developmental Disabilities
Molecular and Vascular MRI of Placenta Accreta
Applying Diffusion Basis Spectrum Imaging to Characterize Human Placenta Immuno-response during normal term and preterm pregnancies
Molecular Regulation of Atherosclerosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD013319-008
Application #
7191376
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Magee-Womens Health Corp.
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 HD
A Randomized Controlled Study of the Efficacy Safety and Acceptability-275013319
/ Magee-Womens Health Corp.
NIH 2004
N01 HD
A Randomized Controlled Study of the Efficacy. Safety. and Acceptabili-275013319
/ Magee-Womens Health Corp.
NIH 2003
N01 HD
A Randomized Controlled Study of the Efficacy, Safety, and Acceptabili-275013319
/ Magee-Womens Health Corp.
NIH 2002
N01 HD
A Randomized Controlled Study of the Efficacy, Safety, and Acceptabili-275013319
/ Magee-Womens Health Corp.
Comments
Be the first to comment on this grant